# Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

> **NCT05871333** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 80 (estimated)

## Conditions studied

- Chemotherapy
- Colorectal Cancer
- Intestinal Mucositis
- Oral Mucositis

## Interventions

- **DRUG:** Losartan 50mg Tab

## Key facts

- **NCT ID:** NCT05871333
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-17
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871333, "Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05871333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*